Social Needs Screening and Chronic Diseases Study (WE CARE)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorUniversity of Massachusetts, Worcester
About this trial
The goal of this clinical trial is to learn if the implementation of the WE CARE social determinants of health (SDOH) screening and referral intervention with an antiracist lens in primary care settings can lead to a meaningful decrease in chronic disease by monitoring conditions such as hypertension, diabetes, depression, hyperlipidemia, and asthma through clinical measures. The main question it aims to answer is:
Does the WE CARE SDOH screening and referral intervention applying an antiracism lens informed implementation strategies have the potential to reduce racial/ethnic health inequities in chronic diseases for minoritized patients?
Eligibility criteria
Qualifiers
Adults and children with diagnosed chronic diseases (hypertension, diabetes mellitus, hyperlipidemia, asthma, or depression) who receive Family Medicine care at one of the study sites.
Children (<18 years of age) with a diagnosis of asthma.
Adult patients (18 years or older) with a diagnosis of diabetes mellitus, hypertension, hyperlipidemia and/or depression.
Disqualifiers
In adults (>18 years of age), those without one or more of the following diagnoses as recorded by ICD-10 codes in their EHR: hypertension, hyperlipidemia, diabetes mellitus, or depression.
In children (<18 years of age), those without a diagnosis of asthma.
Trial design
Treatments tested in this trial
- WE CARE SDOH System
- Standard Pediatric Care
Treatment groups
68,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Massachusetts, Worcester
Lead sponsor
National Institute of Nursing Research (NINR)
Collaborator
Boston University
Collaborator
Boston Medical Center
Collaborator
Family Health Center of Worcester
Collaborator
Source ClinicalTrials.gov